Anticholinergic agents

Gastrointestinal antispasmotic agents: Atropine, Dicyclomine, Glycopyrrolate, Hyoscyamine, Donnatal,  Propantheline.
Urinary antispasmotic agents:Flavoxate, Oxybutynin , Propantheline ,Tolterodine
Dicyclomine (Bentyl ®):Indications: Treatment of functional disturbances of GI motility such as irritable bowel syndrome. Onset: 1-2hrs.  Duration: up to 4 hours.  Dosing: 20mg orally or intramuscularly every 6 hours  (up to 40 mg every 6 hours).   Do not give IV.
Donnatal ®:[Hyoscyamine 0.1037mg + atropine 0.019mg +scopolamine 0.007mg + phenobarbital 16.2mg] Indications: Adjunct in the treatment of PUD, irritable bowel, spastic colitis, spastic bladder, and renal colic. Dosing: 1-2 capsules or tablets three to four times daily or 1 extentab orally every 12 hours; or 5-10 ml of elixir three to four times daily.
Flavoxate (Urispas ®):Indications: Antispasmotic used to provide symptomatic relief of dysuria, nocturia, supra-pubic pain, urgency, and incontinence. Especially useful for treatment of bladder spasticity. Onset: 55-60 min.  Dosing: 100-200mg orally three to four times daily.
Glycopyrrolate (Robinul ®):Indications: Adjunct in the treatment of PUD; inhibits salivation and excessive secretions of the respiratory tract preoperatively; reversal of neuromuscular blockade; control of upper airway secretions. Onset: Oral: with in 50 min; IM: 20-40min ; IV: 10-15min.   
Dosing
: Intraoperative: IV: 0.1 mg q2-3min as needed;   Peptic ulcer: Oral: 1-2mg 2 to 3 times daily.    Decrease secretions: 0.1 to 0.2 mg 3 to 4 times daily  IM/IV or 1 mg orally 2 to 3 times a day.
Hyoscyamine (Levsin ®):Belladonna alkaloid. Indications: Adjunctive therapy  of gastrointestinal disorders caused by spasm;   treatment of urinary hypermotility as well as bladder spasm. Onset: 2-3 min. Duration: 4-6hrs.   
Dosing
: Oral or S.L. : 0.125 to 0.25 mg (1-2 tabs) three to four times daily before meals. 
Levsinex ®: 0.375 to 0.75 mg (1-2 caps) orally every 12 hours.   IV, IM, SC: 0.25-0.5 mg every 6 hours.
Oxybutynin (Ditropan ®):Ditropan ®
Indications
: (Overactive bladder) Antispasmotic for neurogenic bladder (urgency, frequency, urge incontinence) and uninhibited bladder. Onset: 30-60min.  Peak effect: 3-6 hours.  Duration: 6-10 hrs.  Dosing: 5 mg orally 2 to 3 times daily  (up to 4 times a day--maximum). [Supplied: 5 mg tablet and syrup: 5 mg/5 ml]

Ditropan XL ®: 5 to 10 mg orally once daily. May increase dose if needed by 5 mg increments at weekly intervals to a maximum dose of 30mg per day.  [Supplied: 5 mg, 10mg , 15mg tablets]

Oxytrol ®:  Transdermal Patch (3.9 mg/day).  Apply patch twice weekly (every 3 to 4 days).  Use a new application site for each new patch.
Propantheline (Pro-Banthine ®):Indications: Adjunctive therapy of peptic ulcer, irritable bowel syndrome, pancreatitis, ureteral and urinary bladder spasm; reduce duodenal motility during radiologic procedures. Onset: 30-45min.  Duration: 4-6hrs.  
Dosing
: 15mg orally 3 times a day before meals  and 30mg at bedtime.     Supplied: [7.5mg, 15mg tab]
Tolterodine (Detrol ®):Selective anticholinergic agent (increased selectivity for urinary bladder) Indications: Therapy of urinary frequency; urgency; urge incontinence. Reduces bladder spasm. Onset: 1 hr. 
Dosing
: 2 mg orally twice a day, decreasing to 1 mg  twice a day  in the event of bothersome anticholinergic effects.   
Extented release tablets
: 4 mg once daily. May decrease dose to 2 mg once daily if there are bothersome anticholinergic effects.  Supplied:  [1 mg, 2 mg tablets.   Extended release capsules: 2mg, 4 mg.]  

 

Listed dosages are for - Adult patients ONLY.    PLEASE READ THE DISCLAIMER CAREFULLY BEFORE ACCESSING OR USING THIS SITE. BY ACCESSING OR USING THIS SITE, YOU AGREE TO BE BOUND BY THE TERMS AND CONDITIONS SET FORTH IN THE DISCLAIMER. GlobalRPH does not directly or indirectly practice medicine or provide medical services and therefore assumes no liability whatsoever of any kind for the information and data accessed through the Service or for any diagnosis or treatment made in reliance thereon.

David F. McAuley, Pharm.D., R.Ph.
GlobalRPh Inc.

[TOP]

 

ContactPrivacy PolicyDisclaimer

Copyright  © 2005 GlobalRPh Inc.